PATENT CLAIM ANALYSIS

Application Number: 15779420
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "263220"]

Abstract:
The present invention belongs to the field of drug crystals, relates to crystals of thiadiazole derivative DPP-IV inhibitors, and in particular relates to A and B type crystals of the compound as shown in formula 7. The crystals of the present invention have excellent stability. For example, under high temperature, high humidity or light test conditions, the material contents associated with the crystal of the compound of formula 7 do not change significantly. In addition, the crystal of the present invention also has a very good powder flowability and satisfies the requirements of drug preparation and production.

Claim (Index 4):
The crystalline Form A according to  claim 1 , having a powder X-ray diffraction pattern substantially as shown in  FIG. 1 .

Metadata:
- Claim Count in Document: 28.0
- Percentile: 93.0
- Lexical Diversity: 1.69841
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14233902', '15539147', '15565807', '16061279', '13289172']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7410446132305885
- 35 USC 102 Novelty (BERT): 0.4905657350865491
- Combined Prediction Score: 0.7159967254161845
- Mean Citation Score: 224.572202
- Max Citation Score: 233.24199
- Similarity Product: 198.4091507141161

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test